{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:55:00Z","timestamp":1793692500890,"version":"4.5.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03349-x","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:51:25Z","timestamp":1762523485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Associations of metabolic syndrome and its components with complex renal calculi and stone composition: a cross-sectional study"],"prefix":"10.1186","volume":"30","author":[{"given":"Siyuan","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaida","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"3349_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12.","journal-title":"Curr Hypertens Rep"},{"key":"3349_CR2","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640\u20135.","journal-title":"Circulation"},{"key":"3349_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/met.2012.0060","volume":"11","author":"V Silva","year":"2013","unstructured":"Silva V, Stanton KR, Grande AJ. Harmonizing the diagnosis of metabolic syndrome\u2013focusing on abdominal obesity. Metab Syndr Relat Disord. 2013;11:102\u20138.","journal-title":"Metab Syndr Relat Disord"},{"key":"3349_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-01019-y","volume":"30","author":"MS Islam","year":"2024","unstructured":"Islam MS, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M, et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Mol Med. 2024;30:279.","journal-title":"Mol Med"},{"key":"3349_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111679","volume":"211","author":"Z Wu","year":"2024","unstructured":"Wu Z, Luo S, Cai D, Lin W, Hu X, Zhou T, et al. The causal relationship between metabolic syndrome and its components and cardiovascular disease: a mendelian randomization study. Diabetes Res Clin Pract. 2024;211:111679.","journal-title":"Diabetes Res Clin Pract"},{"key":"3349_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jad.2022.11.049","volume":"323","author":"HB Kim","year":"2023","unstructured":"Kim HB, Wolf BJ, Kim JH. Association of metabolic syndrome and its components with the risk of depressive symptoms: a systematic review and meta-analysis of cohort studies. J Affect Disord. 2023;323:46\u201354.","journal-title":"J Affect Disord"},{"key":"3349_CR7","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.numecd.2024.03.017","volume":"34","author":"R Shahid","year":"2024","unstructured":"Shahid R, Hussain M, Ghori MU, Bilal A, Awan FR. Association of hyperuricemia with metabolic syndrome and its components in an adult population of Faisalabad, Pakistan. Nutr Metab Cardiovasc Dis. 2024;34:1554\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"3349_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13201","volume":"72","author":"S Alizadeh","year":"2018","unstructured":"Alizadeh S, Ahmadi M, Ghorbani Nejad B, Djazayeri A, Shab-Bidar S. Metabolic syndrome and its components are associated with increased chronic kidney disease risk: evidence from a meta-analysis on 11 109 003 participants from 66 studies. Int J Clin Pract. 2018;72(8):e13201.","journal-title":"Int J Clin Pract"},{"key":"3349_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.8","volume":"2","author":"SR Khan","year":"2016","unstructured":"Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, et al. Kidney stones. Nat Rev Dis Primers. 2016;2:16008.","journal-title":"Nat Rev Dis Primers"},{"key":"3349_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0022-5347(17)40126-1","volume":"143","author":"JJ Smith 3rd","year":"1990","unstructured":"Smith JJ 3rd, Hollowell JG, Roth RA. Multimodality treatment of complex renal calculi. J Urol. 1990;143:891\u20134.","journal-title":"J Urol"},{"key":"3349_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/CU9.0000000000000149","volume":"18","author":"Y Pak","year":"2024","unstructured":"Pak Y, Kalyagina N, Yagudaev D. Percutaneous nephrolithotomy and laparoscopic surgery efficacy and renal function outcomes for large and complex renal calculi. Curr Urol. 2024;18:268\u201372.","journal-title":"Curr Urol"},{"key":"3349_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-020-0970-9","volume":"21","author":"J Lane","year":"2020","unstructured":"Lane J, Whitehurst L, Hameed BMZ, Tokas T, Somani BK. Correlation of operative time with outcomes of ureteroscopy and stone treatment: a systematic review of literature. Curr Urol Rep. 2020;21:17.","journal-title":"Curr Urol Rep"},{"key":"3349_CR13","volume":"16","author":"HA Abdulrasheed","year":"2024","unstructured":"Abdulrasheed HA, George AO, Ayobami-Ojo PS, Nwachukwu NO, Ajimoti AT, Elsayed W, et al. Current practices and challenges in the management of complex renal stones in Africa: a scoping review. Cureus. 2024;16:e61134.","journal-title":"Cureus"},{"key":"3349_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/PEC.0b013e3182228f10","volume":"27","author":"BL Schissel","year":"2011","unstructured":"Schissel BL, Johnson BK. Renal stones: evolving epidemiology and management. Pediatr Emerg Care. 2011;27:676\u201381.","journal-title":"Pediatr Emerg Care"},{"key":"3349_CR15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae295","volume":"110","author":"M Liu","year":"2025","unstructured":"Liu M, Gao M, Wu J, Zhu Z, Hu J, Chen H, et al. Metabolic syndrome and the risk of kidney stones: evidence from 487 860 UK biobank participants. J Clin Endocrinol Metab. 2025;110:e1211\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"3349_CR16","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.metabol.2012.12.010","volume":"62","author":"YJ Kim","year":"2013","unstructured":"Kim YJ, Kim CH, Sung EJ, Kim SR, Shin HC, Jung WJ. Association of nephrolithiasis with metabolic syndrome and its components. Metabolism. 2013;62:808\u201313.","journal-title":"Metabolism"},{"key":"3349_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.34067\/KID.0002292021","volume":"3","author":"VL Hood","year":"2022","unstructured":"Hood VL, Sternberg KM, de Waal D, Asplin JR, Mulligan C, Callas PW. Association of urine findings with metabolic syndrome traits in a population of patients with nephrolithiasis. Kidney360. 2022;3:317\u201324.","journal-title":"Kidney360"},{"key":"3349_CR18","volume-title":"Guidelines for the diagnosis and treatment of urological and andrological diseases in China (2019 edition)","author":"J Huang","year":"2020","unstructured":"Huang J. Guidelines for the diagnosis and treatment of urological and andrological diseases in China (2019 edition). Beijing: Science Press; 2020."},{"key":"3349_CR19","first-page":"156","volume":"12","author":"The Collaborating Group on Metabolic Syndrome CSGoCMACDS","year":"2004","unstructured":"The Collaborating Group on Metabolic Syndrome CSGoCMACDS. The suggestion about metabolic syndrome by Chinese study group of Chinese Medical Association\/Chinese Diabetes Society. Chin J Diabetes. 2004;12:156\u201361.","journal-title":"Chin J Diabetes"},{"key":"3349_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000001227","author":"SN Dassanayake","year":"2024","unstructured":"Dassanayake SN, Lafont T, Somani BK. Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis. Curr Opin Urol. 2024. https:\/\/doi.org\/10.1097\/MOU.0000000000001227.","journal-title":"Curr Opin Urol"},{"key":"3349_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/570674","volume":"2015","author":"YV Wong","year":"2015","unstructured":"Wong YV, Cook P, Somani BK. The association of metabolic syndrome and urolithiasis. Int J Endocrinol. 2015;2015:570674.","journal-title":"Int J Endocrinol"},{"key":"3349_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/MOU.0000000000001227","volume":"35","author":"SN Dassanayake","year":"2025","unstructured":"Dassanayake SN, Lafont T, Somani BK. Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis. Curr Opin Urol. 2025;35:377\u201384.","journal-title":"Curr Opin Urol"},{"key":"3349_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/13685538.2016.1174987","volume":"19","author":"YC Lee","year":"2016","unstructured":"Lee YC, Huang SP, Juan YS, Huang TY, Liu CC. Impact of metabolic syndrome and its components on kidney stone in aging Taiwanese males. Aging Male. 2016;19:197\u2013201.","journal-title":"Aging Male"},{"key":"3349_CR24","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00345-022-04047-7","volume":"40","author":"MC Park","year":"2022","unstructured":"Park MC, Yoon JH, Park S, Kim SC, Park S, Moon KH, et al. Effects of metabolic syndrome on renal stone progression. World J Urol. 2022;40:1845\u201351.","journal-title":"World J Urol"},{"key":"3349_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-024-01526-4","volume":"24","author":"Z Shen","year":"2024","unstructured":"Shen Z, Xie L, Luo D, Xie H, Chen H, Liu C. Incidence of metabolic syndrome in patients with unilateral or bilateral staghorn renal stones and its impact on percutaneous nephrolithotomy outcomes. BMC Urol. 2024;24:142.","journal-title":"BMC Urol"},{"key":"3349_CR26","volume":"16","author":"M Ivanuta","year":"2024","unstructured":"Ivanuta M, Puia D, Petrila O, Ivanuta AM, Pricop C. The impact of stone composition on treatment strategies for patients with urolithiasis: a narrative review. Cureus. 2024;16:e75345.","journal-title":"Cureus"},{"key":"3349_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.urology.2012.05.011","volume":"80","author":"AO Kadlec","year":"2012","unstructured":"Kadlec AO, Greco K, Fridirici ZC, Hart ST, Vellos T, Turk TM. Metabolic syndrome and urinary stone composition: what factors matter most? Urology. 2012;80:805\u201310.","journal-title":"Urology"},{"key":"3349_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1442-2042.2012.03131.x","volume":"20","author":"ST Cho","year":"2013","unstructured":"Cho ST, Jung SI, Myung SC, Kim TH. Correlation of metabolic syndrome with urinary stone composition. Int J Urol. 2013;20:208\u201313.","journal-title":"Int J Urol"},{"key":"3349_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1053\/j.ajkd.2023.03.017","volume":"82","author":"S Shastri","year":"2023","unstructured":"Shastri S, Patel J, Sambandam KK, Lederer ED. Kidney stone pathophysiology, evaluation and management: core curriculum 2023. Am J Kidney Dis. 2023;82:617\u201334.","journal-title":"Am J Kidney Dis"},{"key":"3349_CR30","doi-asserted-by":"crossref","unstructured":"Abate N, Chandalia M, Cabo-Chan AV Jr., Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65:386\u201392.","DOI":"10.1111\/j.1523-1755.2004.00386.x"},{"key":"3349_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.56434\/j.arch.esp.urol.20257802.28","volume":"78","author":"G Wan","year":"2025","unstructured":"Wan G, Li C, Chen B. Exploration of associated risk factors and development of predictive models for individuals with uric acid stones in the upper urinary system: a retrospective investigation. Arch Esp Urol. 2025;78:207\u201314.","journal-title":"Arch Esp Urol"},{"key":"3349_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5527\/wjn.v1.i1.12","volume":"1","author":"O Aydogdu","year":"2012","unstructured":"Aydogdu O. Urinary stone disease and obesity: different pathologies sharing common biochemical mechanisms. World J Nephrol. 2012;1:12\u20135.","journal-title":"World J Nephrol"},{"key":"3349_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00240-011-0403-9","volume":"40","author":"WL Strohmaier","year":"2012","unstructured":"Strohmaier WL, Wrobel BM, Schubert G. Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis. Urol Res. 2012;40:171\u20135.","journal-title":"Urol Res"},{"key":"3349_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/089277902761402989","volume":"16","author":"HS Do\u011fan","year":"2002","unstructured":"Do\u011fan HS, Sahin A, Cetinkaya Y, Akdo\u011fan B, Ozden E, Kendi S. Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol. 2002;16:649\u201353.","journal-title":"J Endourol"},{"key":"3349_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1513799","volume":"12","author":"L Zhou","year":"2025","unstructured":"Zhou L, Gu W, Jiang Y, Zhang H. Age-stratified analysis of the BMI-kidney stone relationship: findings from a national cross-sectional study. Front Med Lausanne. 2025;12:1513799.","journal-title":"Front Med Lausanne"},{"key":"3349_CR36","volume":"15","author":"NR Almuhanna","year":"2023","unstructured":"Almuhanna NR, Alhussain AM, Aldamanhori RB, Alabdullah QA. Association of chronic hyperglycemia with the risk of urolithiasis. Cureus. 2023;15:e47385.","journal-title":"Cureus"},{"key":"3349_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00240-014-0719-3","volume":"43","author":"JH Masterson","year":"2015","unstructured":"Masterson JH, Woo JR, Chang DC, Chi T, L\u2019Esperance JO, Stoller ML, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis. 2015;43:49\u201353.","journal-title":"Urolithiasis"},{"key":"3349_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.kint.2017.11.011","volume":"93","author":"R Amin","year":"2018","unstructured":"Amin R, Asplin J, Jung D, Bashir M, Alshaikh A, Ratakonda S, et al. Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria. Kidney Int. 2018;93:1098\u2013107.","journal-title":"Kidney Int"},{"key":"3349_CR39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/MOU.0000000000000427","volume":"27","author":"DA Wollin","year":"2017","unstructured":"Wollin DA, Skolarikos A, Preminger GM. Obesity and metabolic stone disease. Curr Opin Urol. 2017;27:422\u20137.","journal-title":"Curr Opin Urol"},{"issue":"6","key":"3349_CR40","doi-asserted-by":"publisher","first-page":"F811","DOI":"10.1152\/ajprenal.00130.2023","volume":"325","author":"M Prochaska","year":"2023","unstructured":"Prochaska M, Menezes C, Ko BS, Coe F, Worcester E. Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls. Am J Physiol Renal Physiol. 2023;325(6):F811-6.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3349_CR41","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.1021\/acs.cgd.3c01083","volume":"23","author":"O Bottrill","year":"2023","unstructured":"Bottrill O, Graham A, Boon M, Mocerino M, Jones F. The impact of sugars on kidney stone formation. Cryst Growth Des. 2023;23:8415\u201325.","journal-title":"Cryst Growth Des"},{"key":"3349_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.atherosclerosis.2005.03.001","volume":"182","author":"A Kontush","year":"2005","unstructured":"Kontush A, de Faria EC, Chantepie S, Chapman MJ. A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis. 2005;182:277\u201385.","journal-title":"Atherosclerosis"},{"key":"3349_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41581-020-00392-1","volume":"17","author":"SR Khan","year":"2021","unstructured":"Khan SR, Canales BK, Dominguez-Gutierrez PR. Randall\u2019s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol. 2021;17:417\u201333.","journal-title":"Nat Rev Nephrol"},{"key":"3349_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.202300452","volume":"46","author":"Y Chao","year":"2023","unstructured":"Chao Y, Li N, Xiong S, Zhang G, Gao S, Dong X. Lipidomics based on liquid chromatography-high resolution mass spectrometry reveals the protective role of peroxisome proliferator-activated receptor alpha on kidney stone formation in mice treated with glyoxylate. J Sep Sci. 2023;46:e2300452.","journal-title":"J Sep Sci"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03349-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03349-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03349-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:05:54Z","timestamp":1762527954000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03349-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3349"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03349-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving humans were approved by The Ethics Committee of Sichuan Provincial People's Hospital (2025-434). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1089"}}